Cross-adaptation theory suggests exposure to controlled stressors can build resilience to unrelated challenges.

NVIDIA unveils Isaac GR00T N1, a humanoid robot foundation model tackling global labor shortages with cutting-edge AI and ...

The companies reported Wednesday that batoclimab showed improvements in myasthenia gravis patients in a Phase 3 trial.

Available, Fully Customizable Foundation Model Brings Generalized Skills and Reasoning to Humanoid RobotsNVIDIA, Google DeepMind and Disney ...

Nvidia (NVDA) announced a portfolio of technologies to supercharge humanoid robot development, including Nvidia Isaac GR00T N1, the world’s ...

People with anxiety can experience decreased microbial diversity and fewer short-chain fatty acid-producing bacteria, recent ...

Treatment with inebilizumab was associated with continued improvement in patients with AChR+ generalized myasthenia gravis, according to 52-week results from the MINT trial.

Traditional healthcare is rooted in generalized care plans, third-party payers and overwhelmed providers and is not built to meet the individual needs of today's patients. Direct-to-consumer ...

(NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

Generalized anxiety disorder (GAD) is a type of excessive worrying that consumes the lives of people who experience it. Symptoms can include fatigue, headaches, shortness of breath, and having a hard ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor ...